Technology

Microsoft rejoined the $2 trillion club

A recovery in Microsoft Corp. shares sees the software giant's market value expected to close above $2 trillion (R35.44 trillion) for the first time in almost six months, as technology equities bounce. Microsoft gained up to 3.4% to $276.76 early Wednesday, joining Apple Inc. as the only firms with market capitalizations more than $2 trillion.

Microsoft  rejoined the $2 trillion club

Microsoft rejoined the $2 trillion club

Share

A recovery in Microsoft Corp. shares sees the software giant’s market value expected to close above $2 trillion (R35.44 trillion) for the first time in almost six months, as technology equities bounce.

Advertisement

Microsoft gained up to 3.4% to $276.76 early Wednesday, joining Apple Inc. as the only firms with market capitalizations more than $2 trillion.

After rebounding 29% from a November low, this is the first time it has surpassed that level since August. Apple has a market capitalization of around $2.44 trillion.

Recent stock increases have coincided with growing investor interest in all things linked to artificial intelligence.

Microsoft stated last month that it is increasing its investment in OpenAI, the owner of a hugely popular chatbot.

On February 7, the business announced a version of its Bing internet-search engine driven on ChatGPT technology.

The stock is gained 15% so far this year, compared to a 16% rise in the Nasdaq 100 Index. Nvidia Corp., a chipmaker that has profited from AI interest, has increased by 55%. This year, Apple has gained 19%.

Microsoft posted mixed quarterly results in January, with the firm warning of a downturn in cloud and commercial software sales.

Separately, Britain’s antitrust authority has tentatively concluded that Microsoft’s $69 billion acquisition of Activision Blizzard Inc. will impair competition in the UK  game industry.

Reporting for Business Tech Africa on the funding, tools and strategy shaping the continent's founders and SMEs.

Was this useful?0 reactions
Rwanda
Read nextTechnology

Rwanda's plan to make advanced medicines at home

Rwanda is preparing to manufacture a class of medicines that has largely been produced outside Africa. The project, led by biotechnology company Bio Usawa, is based in Kigali and is expected to launch in the fourth quarter of 2026.

Vutomi Manzini · readContinue reading